Astellas Pharma Inc (ALPMY)
9.97
+0.27
(+2.78%)
USD |
OTCM |
May 02, 16:00
Astellas Pharma Free Cash Flow: 952.05M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 952.05M |
| September 30, 2023 | 1.059B |
| June 30, 2023 | 1.505B |
| March 31, 2023 | 1.772B |
| December 31, 2022 | 1.372B |
| September 30, 2022 | 1.506B |
| June 30, 2022 | 1.664B |
| March 31, 2022 | 1.612B |
| December 31, 2021 | 1.889B |
| September 30, 2021 | 2.318B |
| June 30, 2021 | 2.457B |
| March 31, 2021 | 2.164B |
| December 31, 2020 | 1.872B |
| September 30, 2020 | 1.358B |
| June 30, 2020 | 1.246B |
| March 31, 2020 | 1.326B |
| December 31, 2019 | 1.408B |
| September 30, 2019 | 1.673B |
| June 30, 2019 | 1.586B |
| March 31, 2019 | 1.863B |
| December 31, 2018 | 2.306B |
| September 30, 2018 | 2.397B |
| June 30, 2018 | 2.226B |
| March 31, 2018 | 2.458B |
| December 31, 2017 | 2.007B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.952B |
| June 30, 2017 | 2.120B |
| March 31, 2017 | 1.729B |
| December 31, 2016 | 2.262B |
| September 30, 2016 | 1.708B |
| June 30, 2016 | 1.601B |
| March 31, 2016 | 1.630B |
| December 31, 2015 | 833.47M |
| September 30, 2015 | 853.48M |
| June 30, 2015 | 664.84M |
| March 31, 2015 | 974.08M |
| December 31, 2014 | 1.221B |
| September 30, 2014 | 1.654B |
| June 30, 2014 | 1.686B |
| March 31, 2014 | 1.579B |
| December 31, 2013 | 1.217B |
| September 30, 2013 | 1.017B |
| June 30, 2013 | 677.15M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Free Cash Flow Range, Past 5 Years
952.05M
Minimum
Dec 2023
2.457B
Maximum
Jun 2021
1.618B
Average
1.586B
Median
Jun 2019
Free Cash Flow Benchmarks
| Takeda Pharmaceutical Co Ltd | -814.80M |
| Nxera Pharma Co Ltd | -43.65M |
| PeptiDream Inc | 78.77M |
| Stemcell Holdings Inc | -- |
| Healios KK | -20.31M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 340.83M |
| Cash from Investing (Quarterly) | -155.23M |
| Cash from Financing (Quarterly) | -690.16M |
| Free Cash Flow Per Share (Quarterly) | 0.1358 |
| Free Cash Flow to Equity (Quarterly) | 23.46M |
| Free Cash Flow to Firm (Quarterly) | 253.89M |
| Free Cash Flow Yield | 5.28% |